(ATLANTA) — The Georgia state Supreme Court reinstated the state’s six-week abortion ban on Monday after a lower court allowed abortions to resume in the state.
The ruling goes into effect at 5 p.m. ET and will remain in place while the court hears the state’s appeal, which was filed by Christopher Carr, the state’s Republican attorney general.
Justice John J. Ellington dissented in part, arguing against the ban being reinstated before the state’s appeal is heard.
“Fundamentally, the State should not be in the business of enforcing laws that have been determined to violate fundamental rights guaranteed to millions of individuals under the Georgia Constitution,” he wrote. “The ‘status quo’ that should be maintained is the state of the law before the challenged laws took effect.”
On Sept. 30, Fulton County Superior Court Judge Robert McBurney ruled that the ban was unconstitutional, writing in his decision that the Georgia state constitution guaranteed the right to “liberty,” which includes a “woman’s right to control what happens to and within her body.” The state appealed the decision two days later.
The ban, which was signed into law in 2019 by Gov. Brian Kemp, prevents abortions from being performed once fetal cardiac activity can be defected, which typically occurs at about six weeks’ gestation — before many women know they’re pregnant — and redefines the word “person” in Georgia to include an embryo or fetus at any stage of development.
There are exceptions for rape or incest until 20 weeks of pregnancy as long as the victim has reported the crime to the police. Additionally, a patient can have an abortion up until 20 weeks if the fetus has defects and would not be able to survive or if the patient’s life is in danger.
The ban was blocked in court but was reinstated after the U.S. Supreme Court overruled Roe v. Wade in 2022.
“Seeing state politicians show such little empathy or respect for Georgians’ health and lives only doubles our resolve to keep fighting until every person has the freedom to make personal medical decisions during pregnancy and the power to chart the course of their own lives,” Julia Kaye, senior staff attorney with the ACLU Reproductive Freedom Project, a litigator on the case, said in a statement.
(NEW YORK) — Breast cancer deaths have fallen by 44% compared to 35 years ago, saving nearly 520,000 lives, according to a new report by the American Cancer Society.
The dramatic decrease is a major milestone in the fight against breast cancer, according to Dr. Lisa Newman, a co-author of the report, released on Tuesday, the start of Breast Cancer Awareness Month.
“This decline is evidence of our success in better treatments for breast cancer, especially with targeted treatments,” Newman, chief of the section of breast surgery at NewYork-Presbyterian/Weill Cornell Medical Center, told ABC News.
Beyond advances in care, Newman noted that mammography has also played a crucial role in detecting cancer earlier.
In April, the U.S. Preventive Services Task Force updated their guidelines, recommending that women at average risk for breast cancer get a mammogram every two years starting at age 40.
However, screening isn’t perfect, Newman stressed.
Women should watch for new lumps, skin changes, and nipple changes, including unusual discharge, pain, and redness.
Even if the last mammogram is clear, women should discuss any changes with a healthcare provider.
Steepest rise in new cases among women under 50
Though breast cancer deaths have dropped, new cases continue to rise.
From 2012 to 2021, breast cancer diagnoses increased by 1% each year, with the steepest rise among women under 50.
The reasons for the increase in diagnoses at a younger age remain unclear, Newman said.
“We speculate that it is related to differences in lifestyle and environment given the obesity epidemic and more women delaying their childbearing years and having fewer pregnancies over their lifetime,” she said.
Racial disparities in breast cancer persist
Yet despite lower overall death rates, racial disparities in breast cancer persist.
American Indian and Alaska Native (AIAN) women have seen no improvement in death rates, while Asian American/Pacific Islander (AAPI) women face the fastest uptick in new cases, with a nearly 3% annual increase.
And despite having 10% fewer cases than white women, AIAN women are 6% more likely to die from the disease and receive fewer regular mammograms.
Black women face a 38% higher chance of dying from breast cancer and have worse outcomes at every stage and subtype, except for localized cancers, compared to white women.
“Studies show that Black women are more likely to receive mammograms at lower-quality facilities, face delays in diagnosing abnormalities, and experience delays in starting and completing treatment,” Newman explained.
Because African American women are more prone to triple negative breast cancer, a particularly deadly form of the disease, Newman said there is a strong push to improve the diversity in clinical trials.
In May of 2024, the ACS launched the VOICES of Black Women Study which will enroll 100,000 Black women aged 25 to 55 and follow them for 30 years.
Newman also pointed out that breast cancer can affect men, especially African American men, who have double the risk compared to White men.
While the report revealed many promising trends in breast cancer, the disease remains the second most common cancer among women in the U.S. after skin cancer and the leading cause of cancer deaths for Black and Hispanic women. In 2024, experts predict over 300,000 new invasive (stage I and above) breast cancer cases with more than 40,000 deaths.
The report’s findings are based on data from the national cancer tracking programs that includes information from the National Cancer Institute and the Centers for Disease Control and Prevention.
(NEW YORK) — Sara Anne Willette has spent more than 1,620 days in isolation since the start of the COVID-19 pandemic.
The New Jersey resident took health precautions in public before the pandemic because of her common variable immunodeficiency, which means she doesn’t make enough antibodies to fight infections.
Simple tasks like going for a walk down the street or taking a trip to the grocery store are laden with safety hurdles and anxiety for Willette.
Stressful tasks, like moving from Iowa to New Jersey during the pandemic for her husband’s new job, are now even more taxing. The two drove overnight to avoid crowds at gas stations and rest stops, and she’s prepared to do it again. The substantial health precautions in her day-to-day life are forcing her and her family to pack up their life once more and look for a new home in the countryside.
“I’m angry that society is largely inaccessible and I have to risk my life for the bare minimum, like medical care,” Willette told ABC News in a phone call. “Why live in civilization if all of it is completely inaccessible?”
More than four years after the start of the COVID-19 pandemic, Willette is among the immunocompromised and disabled Americans who’ve complete changed their way of living to survive.
Her anger was tinged with disappointment as she talked about how the rest of the world has gone back to normal despite the hundreds of people across the country dying from COVID-19 each week amid a summer surge of the virus.
COVID-19 has also been a debilitating event for tens of millions of people who have or are currently experiencing long COVID, which in some cases has been defined as a disability under the Americans with Disabilities Act.
With some lawmakers beginning to propose mask bans in hopes of reducing crime, it’s no longer an option for some to live life normally among the rest of society.
Willette was among the people ABC News checked back in with after previously talking to them about isolating two years after the pandemic began.
Finding a new normal
There are simple joys that Willette misses: having a garden, running, walking, letting her dogs run without a leash and drinking coffee on a porch.
She’s planning on moving to the mountains — somewhere between New Hampshire and Virginia — and gaining enough acreage to allow her and her family to embrace the activities they lost during the pandemic. However, being alone out in the countryside isn’t the goal for Willette.
Rather, she intends to build a pathogen-aware community. That means buying enough land so other disabled, immunocompromised or health-conscious able-bodied people who don’t want to get COVID-19 can join them and create a home of their own.
“We want something that feels like normal but is set up in a way that we decrease harm for everyone in the community,” Willette said. “We can’t do that in an urban area or even in a suburban area. There are too many risks.”
Her mother and mother-in-law intend to move and join Willette, her husband and her son on the property as well.
For Charis Hill, a California resident who has a systemic inflammatory disease and takes immunosuppressive medications, it’s been hard to access an in-person doctor’s appointment since many safety precautions for COVID-19 are no longer being taken in medical care facilities.
As someone with “high-level medical needs,” the lack of COVID precautions has even made seeking routine care a challenge.
“Just the fact that a medical environment that is supposed to know what a virus can do, most medical environments no longer require masking, and that’s what makes it unsafe for people like me to go, for anybody to go,” Hill told ABC over the phone.
“The impact of the delayed care, where people can’t go get routine care, that’s going to affect the whole health care system. Emergencies happen because of delayed care.”
Despite the stress and forced isolation, they find moments of joy growing their own food in their garden, and stay busy by working to reduce the local feral cat population through Trap-Neuter-Return practices.
They break their isolation monthly to meet at a park with a close-knit circle of friends who take similar safety precautions — they’re all masked, socially distanced and have tested beforehand.
“That’s really the only way for me to meet strangers and also to make new friends,” Hill said.
Mask bans would further bar immunocompromised people from public life, according to Hill.
Such bans “make it unsafe for us to exist,” Hill noted, because people may feel pressure not to wear masks when they’re sick or if immunocompromised people are worried about backlash for doing so.
With more people testing positive for COVID this summer, and with the fall and winter virus season ahead, Hill says society’s “new normal” should involve free testing, vaccines, access to at-home antiviral therapy paxlovid and flexible hybrid working options to mitigate the spread of illnesses.
“We need a new normal, and a new normal that is equitable for everyone, and that not only prioritizes high risk people, but that also reduces infection overall,” Hill said.
COVID concerns for the immunocompromised population
Immunocompromised people — about 3% of the adult population in the U.S., according to the National Institutes of Health — continue to face potentially serious medical complications or death when it comes to COVID-19. Even for those who were not previously at risk now have seen life-changing heath impacts.
“Long COVID can happen to anyone, and I have certainly seen young, healthy, vigorous athletes have prolonged, debilitating symptoms from long COVID,” Dr. Jeannina Smith, the medical director of University of Wisconsin’s Transplant Infectious Disease Program, told ABC over the phone.
However, society has largely appeared to have moved on. The CDC stopped recording some COVID-19 related data and some politicians have proposed mask bans as a potential solution to crime.
“It takes us a step back for public health,” Hill said. “We have other pandemics that are coming, and it’s going to make it harder to reenact mask mandates if we need them in the future.”
For the immunocompromised, regular society could seem like a minefield, according to Dr. Cassandra M. Pierre, the medical director of Public Health Programs and the associate hospital epidemiologist at Boston Medical Center.
She noted that people at higher risk for complications “are still, unfortunately, in our hospitals today. We see that they have this forced risk of going on to develop critical COVID or potentially even die. This is still occurring. COVID is still happening.”
This is all happening despite a better understanding of disease transmission and the information needed to be better equipped to empower communities to protect their health, Pierre added.
Patients have been harassed or mocked for wearing masks in public, Dr. Jeannina Smith noted, despite international and national medical organizations emphasizing the importance of mask wearing as a mitigation tactic for illnesses. Hill has experienced this first hand.
“You can’t look at someone and know that they’re receiving immunosuppression for an organ transplant or an autoimmune condition, and they remain at risk,” Smith said.
“Even if you don’t have individual risk, any person can still spread COVID to someone who has higher risk,” she said. “In fact, much of the spread continues to be from asymptomatic person. The very idea that we would criminalize wanting to protect our fellow citizens is pretty horrific.”
The federal government has recently changed its tune amid the summer COVID spike and is preparing for the upcoming fall and winter season by approving and granting emergency use authorization for updated COVID-19 vaccines and restarting its free at-home COVID tests program.
(WASHINGTON) — The U.S. Food and Drug Administration authorized the first over-the-counter combination COVID-19 and flu test outside of emergency use on Monday evening.
This means the Healgen Rapid Check COVID-19/Flu A&B Antigen Test is available without a prescription. The FDA said the test is for those who are experiencing respiratory symptoms.
While there are other over-the-counter combination tests currently available, this is the first to be marketed to consumers using the traditional approval pathway outside of a public health emergency.
The new combination test uses a nasal swab sample to deliver at-home results for COVID-19 and influenza in approximately 15 minutes.
Healgen’s test detects proteins from both SARS-CoV-2, which is the virus that causes COVID-19, and influenza A and B, which are the viruses that cause flu.
“As we enter this year’s annual flu season with respiratory illnesses such as COVID-19 on many of our minds, our ability to detect these pathogens effectively and efficiently can be impactful on our daily lives,” said Dr. Michelle Tarver, acting director of the FDA’s Center for Devices and Radiological Health, in a statement. “Today’s authorization expands the options for individuals with respiratory symptoms to receive information about their health from the comfort of their home.”
“The FDA continues to take actions that support the development and availability of at-home tests for a variety of medical conditions,” the statement continued.
The test is for use by people 14 and older who can take their own sample, or those 2 and older, who have a sample taken by an adult, according to the federal health agency.
Data reviewed by the FDA found the test correctly identified 99% of negative and 92% of positive COVID samples. Additionally, the test correctly identified 99.9% of negative flu samples, and 92.5% and 90.5% of positive flu samples, respectively.
Like other over-the-counter COVID-19 antigen tests, the FDA says a positive test result likely means a patient is positive while a negative rest result may require a confirmation test.
However, people who test negative and continue to experience symptoms including cough, fever and shortness of breath should follow up with their health care provider, the FDA says. Similarity, the FDA says those who test positive should take appropriate precautions to avoid spreading either virus and should also follow up with their health care provider.